{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:54:22Z","timestamp":1760298862989},"reference-count":21,"publisher":"Informa UK Limited","issue":"sup4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1179\/joc.2004.16.supplement-1.112","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T14:22:05Z","timestamp":1389277325000},"page":"112-116","source":"Crossref","is-referenced-by-count":2,"title":["Management of Cancer Anemia"],"prefix":"10.1080","volume":"16","author":[{"given":"A.","family":"Grossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,12,13]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","unstructured":"Skillings JR, Roger-Melamed I, Nabholtz JM, et al. An epidemiological review of anaemia in cancer chemotherapy in Canada. Eur J Cancer 1995; 31 Suppl 5: abstr.","DOI":"10.1016\/0959-8049(95)96128-Z"},{"issue":"2","key":"CIT0002","first-page":"13","volume":"34","author":"Cella D","year":"1997","journal-title":"Semin Hematol"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06939.x"},{"issue":"1","key":"CIT0005","first-page":"68","volume":"92","author":"Hellstrom-Lindberg E","year":"1998","journal-title":"Treatment of anemia in myelodysplastic syndromes with gran-ulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03583.x"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.07.177"},{"issue":"12","key":"CIT0008","first-page":"1286","volume":"87","author":"Alessandrino EP","year":"2002","journal-title":"A statement from the Italian Society of Hematology. Haematologica"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.2001.19.11.2875","volume":"19","author":"Gabrilove JL","year":"2001","journal-title":"J Clin Oncol"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1746"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Smith RE Jr, Jaiyesimi IA, Meza LA, et al. Novel ery-thropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer. Br J Cancer. 2001; 84, Suppl.1: 24-30.","DOI":"10.1054\/bjoc.2001.1749"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600465"},{"key":"CIT0013","doi-asserted-by":"crossref","unstructured":"Glaspy J, Jadeja J, Justice G et al. Randomized, active controlled, phase 1\/2, dose escalation study of NESP admin-istered weekly and every 2 weeks in patients with solid tumors. Proc Am Soc Clin Oncol 2001; 20: 387a (abstr).","DOI":"10.1016\/S0959-8049(01)81805-0"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04448.x"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(03)00456-8"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1997.15.3.1218","volume":"15","author":"Glaspy J","year":"1997","journal-title":"Procrit Study Group. J Clin Oncol"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)01163-X"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14567-9"},{"issue":"11","key":"CIT0020","first-page":"2865","volume":"19","author":"Littlewood TJ","year":"2001","journal-title":"Effects of epoetin alpha on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a ran-domized, double-blind, placebo-controlled trial. J Clin Oncol"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2003.08.020"},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Olsen NV. Central Nervous System frontiers for use of Erythropoietin C I D 2003; 37, Suppl 4: 323-330.","DOI":"10.1086\/376912"},{"issue":"8","key":"CIT0023","first-page":"37","volume":"18","author":"Casadevall N","year":"2003","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T02:42:33Z","timestamp":1565059353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2004.16.Supplement-1.112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":21,"journal-issue":{"issue":"sup4","published-online":{"date-parts":[[2013,12,13]]},"published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1179\/joc.2004.16.Supplement-1.112"],"URL":"https:\/\/doi.org\/10.1179\/joc.2004.16.supplement-1.112","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}